Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

A collaboration of scientists at the University of Manchester and the University of Birmingham has explored a more effective ...

In the wake of recent government policy aimed at actively replacing animal models in drug discovery, we consider a possible ...

SOMERVILLE, MA, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- In the precise environment of a modern medicinal ...

A unique research at the Qatar Biomedical Research Institute (QBRI), a part of Hamad Bin Khalifa University, is leading a ...

Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...

Chinese herbal medicines have given birth to many classic drugs, but their complex ingredients and unclear mechanisms slow ...

A new research framework published in Engineering provides a structured, high-efficiency approach to innovative drug discovery from Chinese herbal ...

Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...

ChromatographyOnline.com marked Earth Day with environment-focused content and expert interviews while also highlighting ...

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences over the ...

In this webinar, Kyle Kern and Isuru Karunaratne will explore how high-resolution imaging enables functional analysis of ...